Influence of primary and secondary prevention indications on anxiety about the implantable cardioverter-defibrillator

Abstract Background Implantable cardioverter-defibrillators (ICDs) have been established for primary and secondary prevention of fatal arrhythmias. However, little is known about the influence of ICD indications on quality of life (QOL) and psychological disturbances. This study aimed to examine whe...

Full description

Saved in:
Bibliographic Details
Published inJournal of arrhythmia Vol. 32; no. 2; pp. 102 - 107
Main Authors Rahmawati, Anita, MD, Chishaki, Akiko, MD, PhD, Ohkusa, Tomoko, MD, PhD, Sawatari, Hiroyuki, RN, PhD, Tsuchihashi-Makaya, Miyuki, RN, PhD, Ohtsuka, Yuko, RN, Nakai, Mori, MD, PhD, Miyazono, Mami, RN, PhD, Hashiguchi, Nobuko, RN, PhD, Sakurada, Harumizu, MD, PhD, Takemoto, Masao, MD, PhD, Mukai, Yasushi, MD, PhD, Inoue, Shujirou, MD, PhD, Sunagawa, Kenji, MD, PhD, Chishaki, Hiroaki, MD
Format Journal Article
LanguageEnglish
Published Japan John Wiley & Sons, Inc 01.04.2016
Elsevier
Wiley
Subjects
Online AccessGet full text
ISSN1880-4276
1883-2148
DOI10.1016/j.joa.2015.10.002

Cover

Abstract Abstract Background Implantable cardioverter-defibrillators (ICDs) have been established for primary and secondary prevention of fatal arrhythmias. However, little is known about the influence of ICD indications on quality of life (QOL) and psychological disturbances. This study aimed to examine whether there were differences in QOL and psychological distress in patients that have an ICD for primary or secondary prevention of fatal arrhythmias. Methods A multicenter survey of 179 consecutive outpatients (29.1% primary prevention) with ICD implantations completed the Short Form-8 (SF-8), Beck Depression Inventory (BDI), Impact of Event Scale-Revised (IES-R), State-Trait Anxiety Inventory (STAI), and Worries about ICD (WAICD). Results Patients with an ICD for primary prevention had a higher trait anxiety score and worries about ICD score than patients with an ICD for secondary prevention (41.7±12.4 vs. 34.7±12.3, p =0.001 and 39.6±18.0 vs. 30.0±18.9, p =0.002, respectively), even after adjusting for demographic and clinical characteristics. In multivariable analysis of variance, primary prevention ICD recipients reported a poorer QOL on the vitality subscale of the SF-8. Conclusions In our study population, which mostly consisted of New York Heart Association (NYHA) class I and II subjects, primary prevention ICD recipients were more prone to experience worries about their ICD, anxiety, and a poorer QOL compared to secondary prevention ICD recipients. In clinical practice, primary prevention ICD patients should be closely monitored. If warranted, they should be offered psychological intervention, as anxiety and low QOL were predictors of mortality.
AbstractList Background: Implantable cardioverter-defibrillators (ICDs) have been established for primary and secondary prevention of fatal arrhythmias. However, little is known about the influence of ICD indications on quality of life (QOL) and psychological disturbances. This study aimed to examine whether there were differences in QOL and psychological distress in patients that have an ICD for primary or secondary prevention of fatal arrhythmias. Methods: A multicenter survey of 179 consecutive outpatients (29.1% primary prevention) with ICD implantations completed the Short Form-8 (SF-8), Beck Depression Inventory (BDI), Impact of Event Scale-Revised (IES-R), State-Trait Anxiety Inventory (STAI), and Worries about ICD (WAICD). Results: Patients with an ICD for primary prevention had a higher trait anxiety score and worries about ICD score than patients with an ICD for secondary prevention (41.7±12.4 vs. 34.7±12.3, p=0.001 and 39.6±18.0 vs. 30.0±18.9, p=0.002, respectively), even after adjusting for demographic and clinical characteristics. In multivariable analysis of variance, primary prevention ICD recipients reported a poorer QOL on the vitality subscale of the SF-8. Conclusions: In our study population, which mostly consisted of New York Heart Association (NYHA) class I and II subjects, primary prevention ICD recipients were more prone to experience worries about their ICD, anxiety, and a poorer QOL compared to secondary prevention ICD recipients. In clinical practice, primary prevention ICD patients should be closely monitored. If warranted, they should be offered psychological intervention, as anxiety and low QOL were predictors of mortality.
Background Implantable cardioverter‐defibrillators (ICDs) have been established for primary and secondary prevention of fatal arrhythmias. However, little is known about the influence of ICD indications on quality of life (QOL) and psychological disturbances. This study aimed to examine whether there were differences in QOL and psychological distress in patients that have an ICD for primary or secondary prevention of fatal arrhythmias. Methods A multicenter survey of 179 consecutive outpatients (29.1% primary prevention) with ICD implantations completed the Short Form‐8 (SF‐8), Beck Depression Inventory (BDI), Impact of Event Scale‐Revised (IES‐R), State‐Trait Anxiety Inventory (STAI), and Worries about ICD (WAICD). Results Patients with an ICD for primary prevention had a higher trait anxiety score and worries about ICD score than patients with an ICD for secondary prevention (41.7±12.4 vs. 34.7±12.3, p=0.001 and 39.6±18.0 vs. 30.0±18.9, p=0.002, respectively), even after adjusting for demographic and clinical characteristics. In multivariable analysis of variance, primary prevention ICD recipients reported a poorer QOL on the vitality subscale of the SF‐8. Conclusions In our study population, which mostly consisted of New York Heart Association (NYHA) class I and II subjects, primary prevention ICD recipients were more prone to experience worries about their ICD, anxiety, and a poorer QOL compared to secondary prevention ICD recipients. In clinical practice, primary prevention ICD patients should be closely monitored. If warranted, they should be offered psychological intervention, as anxiety and low QOL were predictors of mortality.
Implantable cardioverter-defibrillators (ICDs) have been established for primary and secondary prevention of fatal arrhythmias. However, little is known about the influence of ICD indications on quality of life (QOL) and psychological disturbances. This study aimed to examine whether there were differences in QOL and psychological distress in patients that have an ICD for primary or secondary prevention of fatal arrhythmias. A multicenter survey of 179 consecutive outpatients (29.1% primary prevention) with ICD implantations completed the Short Form-8 (SF-8), Beck Depression Inventory (BDI), Impact of Event Scale-Revised (IES-R), State-Trait Anxiety Inventory (STAI), and Worries about ICD (WAICD). In our study population, which mostly consisted of New York Heart Association (NYHA) class I and II subjects, primary prevention ICD recipients were more prone to experience worries about their ICD, anxiety, and a poorer QOL compared to secondary prevention ICD recipients. In clinical practice, primary prevention ICD patients should be closely monitored. If warranted, they should be offered psychological intervention, as anxiety and low QOL were predictors of mortality.
Implantable cardioverter-defibrillators (ICDs) have been established for primary and secondary prevention of fatal arrhythmias. However, little is known about the influence of ICD indications on quality of life (QOL) and psychological disturbances. This study aimed to examine whether there were differences in QOL and psychological distress in patients that have an ICD for primary or secondary prevention of fatal arrhythmias.BACKGROUNDImplantable cardioverter-defibrillators (ICDs) have been established for primary and secondary prevention of fatal arrhythmias. However, little is known about the influence of ICD indications on quality of life (QOL) and psychological disturbances. This study aimed to examine whether there were differences in QOL and psychological distress in patients that have an ICD for primary or secondary prevention of fatal arrhythmias.A multicenter survey of 179 consecutive outpatients (29.1% primary prevention) with ICD implantations completed the Short Form-8 (SF-8), Beck Depression Inventory (BDI), Impact of Event Scale-Revised (IES-R), State-Trait Anxiety Inventory (STAI), and Worries about ICD (WAICD).METHODSA multicenter survey of 179 consecutive outpatients (29.1% primary prevention) with ICD implantations completed the Short Form-8 (SF-8), Beck Depression Inventory (BDI), Impact of Event Scale-Revised (IES-R), State-Trait Anxiety Inventory (STAI), and Worries about ICD (WAICD).Patients with an ICD for primary prevention had a higher trait anxiety score and worries about ICD score than patients with an ICD for secondary prevention (41.7±12.4 vs. 34.7±12.3, p=0.001 and 39.6±18.0 vs. 30.0±18.9, p=0.002, respectively), even after adjusting for demographic and clinical characteristics. In multivariable analysis of variance, primary prevention ICD recipients reported a poorer QOL on the vitality subscale of the SF-8.RESULTSPatients with an ICD for primary prevention had a higher trait anxiety score and worries about ICD score than patients with an ICD for secondary prevention (41.7±12.4 vs. 34.7±12.3, p=0.001 and 39.6±18.0 vs. 30.0±18.9, p=0.002, respectively), even after adjusting for demographic and clinical characteristics. In multivariable analysis of variance, primary prevention ICD recipients reported a poorer QOL on the vitality subscale of the SF-8.In our study population, which mostly consisted of New York Heart Association (NYHA) class I and II subjects, primary prevention ICD recipients were more prone to experience worries about their ICD, anxiety, and a poorer QOL compared to secondary prevention ICD recipients. In clinical practice, primary prevention ICD patients should be closely monitored. If warranted, they should be offered psychological intervention, as anxiety and low QOL were predictors of mortality.CONCLUSIONSIn our study population, which mostly consisted of New York Heart Association (NYHA) class I and II subjects, primary prevention ICD recipients were more prone to experience worries about their ICD, anxiety, and a poorer QOL compared to secondary prevention ICD recipients. In clinical practice, primary prevention ICD patients should be closely monitored. If warranted, they should be offered psychological intervention, as anxiety and low QOL were predictors of mortality.
Abstract Background Implantable cardioverter-defibrillators (ICDs) have been established for primary and secondary prevention of fatal arrhythmias. However, little is known about the influence of ICD indications on quality of life (QOL) and psychological disturbances. This study aimed to examine whether there were differences in QOL and psychological distress in patients that have an ICD for primary or secondary prevention of fatal arrhythmias. Methods A multicenter survey of 179 consecutive outpatients (29.1% primary prevention) with ICD implantations completed the Short Form-8 (SF-8), Beck Depression Inventory (BDI), Impact of Event Scale-Revised (IES-R), State-Trait Anxiety Inventory (STAI), and Worries about ICD (WAICD). Results Patients with an ICD for primary prevention had a higher trait anxiety score and worries about ICD score than patients with an ICD for secondary prevention (41.7±12.4 vs. 34.7±12.3, p =0.001 and 39.6±18.0 vs. 30.0±18.9, p =0.002, respectively), even after adjusting for demographic and clinical characteristics. In multivariable analysis of variance, primary prevention ICD recipients reported a poorer QOL on the vitality subscale of the SF-8. Conclusions In our study population, which mostly consisted of New York Heart Association (NYHA) class I and II subjects, primary prevention ICD recipients were more prone to experience worries about their ICD, anxiety, and a poorer QOL compared to secondary prevention ICD recipients. In clinical practice, primary prevention ICD patients should be closely monitored. If warranted, they should be offered psychological intervention, as anxiety and low QOL were predictors of mortality.
Implantable cardioverter-defibrillators (ICDs) have been established for primary and secondary prevention of fatal arrhythmias. However, little is known about the influence of ICD indications on quality of life (QOL) and psychological disturbances. This study aimed to examine whether there were differences in QOL and psychological distress in patients that have an ICD for primary or secondary prevention of fatal arrhythmias. A multicenter survey of 179 consecutive outpatients (29.1% primary prevention) with ICD implantations completed the Short Form-8 (SF-8), Beck Depression Inventory (BDI), Impact of Event Scale-Revised (IES-R), State-Trait Anxiety Inventory (STAI), and Worries about ICD (WAICD). Patients with an ICD for primary prevention had a higher trait anxiety score and worries about ICD score than patients with an ICD for secondary prevention (41.7±12.4 vs. 34.7±12.3, p=0.001 and 39.6±18.0 vs. 30.0±18.9, p=0.002, respectively), even after adjusting for demographic and clinical characteristics. In multivariable analysis of variance, primary prevention ICD recipients reported a poorer QOL on the vitality subscale of the SF-8. In our study population, which mostly consisted of New York Heart Association (NYHA) class I and II subjects, primary prevention ICD recipients were more prone to experience worries about their ICD, anxiety, and a poorer QOL compared to secondary prevention ICD recipients. In clinical practice, primary prevention ICD patients should be closely monitored. If warranted, they should be offered psychological intervention, as anxiety and low QOL were predictors of mortality.
Audience Academic
Author Sawatari, Hiroyuki, RN, PhD
Hashiguchi, Nobuko, RN, PhD
Sakurada, Harumizu, MD, PhD
Ohtsuka, Yuko, RN
Nakai, Mori, MD, PhD
Chishaki, Hiroaki, MD
Inoue, Shujirou, MD, PhD
Miyazono, Mami, RN, PhD
Takemoto, Masao, MD, PhD
Tsuchihashi-Makaya, Miyuki, RN, PhD
Sunagawa, Kenji, MD, PhD
Mukai, Yasushi, MD, PhD
Chishaki, Akiko, MD, PhD
Rahmawati, Anita, MD
Ohkusa, Tomoko, MD, PhD
AuthorAffiliation g Department of Healthcare Management, College of Healthcare Management, Fukuoka, Japan
b Department of Health Sciences, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
a Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
c Kirameki Project Carrier Support Center, Kyushu University Hospital, Fukuoka, Japan
e Tokyo Metropolitan Health and Medical Treatment Corporation Ookubo Hospital, Tokyo, Japan
f School of Nursing, Fukuoka Prefectural University, Fukuoka, Japan
d School of Nursing, Kitasato University, Kanagawa, Japan
AuthorAffiliation_xml – name: c Kirameki Project Carrier Support Center, Kyushu University Hospital, Fukuoka, Japan
– name: g Department of Healthcare Management, College of Healthcare Management, Fukuoka, Japan
– name: e Tokyo Metropolitan Health and Medical Treatment Corporation Ookubo Hospital, Tokyo, Japan
– name: f School of Nursing, Fukuoka Prefectural University, Fukuoka, Japan
– name: a Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
– name: d School of Nursing, Kitasato University, Kanagawa, Japan
– name: b Department of Health Sciences, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
Author_xml – sequence: 1
  fullname: Rahmawati, Anita, MD
– sequence: 2
  fullname: Chishaki, Akiko, MD, PhD
– sequence: 3
  fullname: Ohkusa, Tomoko, MD, PhD
– sequence: 4
  fullname: Sawatari, Hiroyuki, RN, PhD
– sequence: 5
  fullname: Tsuchihashi-Makaya, Miyuki, RN, PhD
– sequence: 6
  fullname: Ohtsuka, Yuko, RN
– sequence: 7
  fullname: Nakai, Mori, MD, PhD
– sequence: 8
  fullname: Miyazono, Mami, RN, PhD
– sequence: 9
  fullname: Hashiguchi, Nobuko, RN, PhD
– sequence: 10
  fullname: Sakurada, Harumizu, MD, PhD
– sequence: 11
  fullname: Takemoto, Masao, MD, PhD
– sequence: 12
  fullname: Mukai, Yasushi, MD, PhD
– sequence: 13
  fullname: Inoue, Shujirou, MD, PhD
– sequence: 14
  fullname: Sunagawa, Kenji, MD, PhD
– sequence: 15
  fullname: Chishaki, Hiroaki, MD
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27092190$$D View this record in MEDLINE/PubMed
BookMark eNqFU8uO0zAUjdAg5gEfwAZFYsMmxa_EzgZpNOJRNNIsgLXlx03HIbWLnRT69zhtB1GEQF7Y9_qco-t7jy-LMx88FMVzjBYY4eZ1v-iDWhCE6xwvECKPigssBK0IZuJsf0YVI7w5Ly5T6hGqBcP4SXFOOGoJbtFFMS19N0zgDZShKzfRrVXclcrbMoEJ3s7RJsIW_OiCL523zqj5mMocKv_DwZjxOkxjOd5D6dabQflR6QFKo6J1YQtxhFhZ6JyObhjUGOLT4nGnhgTPjvtV8eXd2883H6rbu_fLm-vbyvCWkarltFUt4ritLSWoa5ghQtVCC9FyIbBtLFKNVQ1qFDU4AzVujKm11Z2mytCrYnnQtUH18vg6GZST-0SIK6ni6MwAUjNiuNEIWwQMgxWWtZ1WNRBFuSFd1npz0NpMeg3W5I5ENZyInt54dy9XYSuZILTmLAu8OgrE8G2CNMq1SwZyRzyEKUnMBREUt4Jm6MsDdKVyac53ISuaGS6vOUGEE05n1OIvqLwsrF0eXu54zp8QXvz-hF-1P9ghA_gBYGJIKUInjRv3487KbpAYydl4spfZeHI23pzKxstM_AfzQfxfnObA-Z7r3P2fID_eXVO8Jx5HAdk7WwdRmsH5bMzhK-wg9WGKPttKYpmIRPLT_A_mb4BrhDBDjP4ERvcD2g
CitedBy_id crossref_primary_10_1161_JAHA_119_014253
crossref_primary_10_1111_pace_13427
crossref_primary_10_1093_eurjcn_zvae067
crossref_primary_10_1016_j_ijcha_2021_100779
crossref_primary_10_3390_ijerph191912830
crossref_primary_10_1002_joa3_12086
crossref_primary_10_1016_j_hrthm_2022_06_025
crossref_primary_10_4103_abr_abr_338_21
crossref_primary_10_1016_j_genhosppsych_2017_12_002
crossref_primary_10_1111_anec_70017
crossref_primary_10_1371_journal_pone_0314978
crossref_primary_10_1016_j_ijcha_2020_100704
crossref_primary_10_1111_sdi_12937
crossref_primary_10_1111_pace_13442
crossref_primary_10_1016_j_hrcr_2023_05_006
Cites_doi 10.1176/appi.ajp.159.9.1570
10.1111/pace.12108
10.1161/CIRCULATIONAHA.104.526673
10.1097/00005053-200203000-00006
10.1016/j.genhosppsych.2009.01.003
10.1111/j.1540-8159.2007.00694.x
10.1186/1477-7525-5-64
10.4037/ajcc2005.14.4.294
10.1253/circj.CJ-13-1129
10.1111/pace.12490
10.1016/S1099-5129(03)00078-3
10.1253/circj.CJ-88-0022
10.1111/j.1524-4733.2008.00449.x
10.1002/(SICI)1097-4679(200006)56:6<793::AID-JCLP8>3.0.CO;2-4
10.1016/j.jacc.2015.04.029
10.1016/j.joa.2012.03.014
10.1016/j.jacc.2010.06.059
10.1016/j.jacc.2008.02.032
10.1253/circj.69.625
10.1111/j.1540-8159.2008.02196.x
10.1016/j.acvd.2014.06.009
10.1016/j.janxdis.2007.02.007
10.1001/jama.297.17.1909
10.4065/80.2.232
10.1016/j.amjcard.2003.11.022
10.1111/j.1540-8159.2006.00409.x
10.1001/archpsyc.1961.01710120031004
10.1253/circj.CJ-12-1116
10.1161/CIRCULATIONAHA.106.178233
10.1111/j.1540-8159.2012.03497.x
ContentType Journal Article
Copyright Japanese Heart Rhythm Society
2016 Japanese Heart Rhythm Society
COPYRIGHT 2016 John Wiley & Sons, Inc.
2015 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved. 2015 Japanese Heart Rhythm Society
Copyright_xml – notice: Japanese Heart Rhythm Society
– notice: 2016 Japanese Heart Rhythm Society
– notice: COPYRIGHT 2016 John Wiley & Sons, Inc.
– notice: 2015 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved. 2015 Japanese Heart Rhythm Society
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.1016/j.joa.2015.10.002
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList



MEDLINE - Academic

PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1883-2148
EndPage 107
ExternalDocumentID oai_doaj_org_article_b42c7cb01d0e41ed8d49fba5e2a37c2f
PMC4823574
A720272733
27092190
10_1016_j_joa_2015_10_002
JOA3102
1_s2_0_S1880427615001404
Genre article
Journal Article
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GroupedDBID 0R~
0SF
1OC
24P
2WC
4.4
457
4G.
53G
5GY
6I.
7-5
7X7
8FI
8FJ
AACTN
AAEDT
AAEDW
AAFTH
AAHHS
AAIKJ
AALRI
AAXUO
ABMAC
ABUWG
ACCFJ
ACCMX
ACGFS
ACXQS
ADBBV
ADEZE
ADKYN
ADPDF
ADVLN
ADZMN
ADZOD
AEEZP
AEKER
AEQDE
AEXQZ
AFKRA
AGHFR
AGYEJ
AITUG
AIWBW
AJBDE
AKRWK
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMRAJ
AOIJS
AVUZU
BAWUL
BCNDV
BENPR
BKOMP
BPHCQ
BVXVI
CCPQU
DIK
EBS
EIHBH
EJD
FDB
FIRID
FNPLU
FYUFA
GBLVA
GROUPED_DOAJ
HMCUK
HYE
HZ~
IAO
IHR
IPNFZ
ITC
IXB
JMI
JSF
JSH
KQ8
M41
MOJWN
NCXOZ
O-L
O9-
OK1
OVD
OVEED
PIMPY
PQQKQ
PROAC
Q38
RIG
RJT
ROL
RPM
RZJ
SDF
SEL
SSZ
TEORI
TKC
UKHRP
WIN
AAYWO
AAYXX
ACVFH
ADCNI
AEUPX
AFPUW
AIGII
AKBMS
AKYEP
CITATION
PHGZM
PHGZT
NPM
PMFND
7X8
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
PUEGO
5PM
ID FETCH-LOGICAL-c7942-9739a907195d320f64c28a58b8897881d6d0a6da606a3c1071b16cc5bdbfb3ac3
IEDL.DBID DOA
ISSN 1880-4276
IngestDate Wed Aug 27 01:32:21 EDT 2025
Thu Aug 21 14:35:40 EDT 2025
Thu Sep 04 16:37:48 EDT 2025
Tue Jun 17 21:35:22 EDT 2025
Tue Jun 10 20:12:53 EDT 2025
Wed Feb 19 02:02:29 EST 2025
Tue Jul 01 04:07:38 EDT 2025
Thu Apr 24 23:02:15 EDT 2025
Wed Jan 22 16:46:47 EST 2025
Tue Feb 25 20:00:54 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Secondary prevention
Anxiety
Primary prevention
Implantable cardioverter-defibrillator
Quality of life
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c7942-9739a907195d320f64c28a58b8897881d6d0a6da606a3c1071b16cc5bdbfb3ac3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doaj.org/article/b42c7cb01d0e41ed8d49fba5e2a37c2f
PMID 27092190
PQID 1782831983
PQPubID 23479
PageCount 6
ParticipantIDs doaj_primary_oai_doaj_org_article_b42c7cb01d0e41ed8d49fba5e2a37c2f
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4823574
proquest_miscellaneous_1782831983
gale_infotracmisc_A720272733
gale_infotracacademiconefile_A720272733
pubmed_primary_27092190
crossref_citationtrail_10_1016_j_joa_2015_10_002
crossref_primary_10_1016_j_joa_2015_10_002
wiley_primary_10_1016_j_joa_2015_10_002_JOA3102
elsevier_clinicalkeyesjournals_1_s2_0_S1880427615001404
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate April 2016
PublicationDateYYYYMMDD 2016-04-01
PublicationDate_xml – month: 04
  year: 2016
  text: April 2016
PublicationDecade 2010
PublicationPlace Japan
PublicationPlace_xml – name: Japan
PublicationTitle Journal of arrhythmia
PublicationTitleAlternate J Arrhythm
PublicationYear 2016
Publisher John Wiley & Sons, Inc
Elsevier
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: Elsevier
– name: Wiley
References 2002; 190
2005; 111
1997
2002; 159
2005; 80
2011; 57
2007; 30
2008; 51
2012; 35
2012; 76
2006; 114
2005; 69
2009; 12
2014; 107
2013; 36
2009; 32
2004; 93
2009; 31
2013; 77
1961; 4
2000; 56
2007; 297
2015; 65
2014; 37
2006; 29
2003; 5
2012; 28
2007; 5
2008; 22
2005; 14
e_1_2_8_27_2
e_1_2_8_28_2
e_1_2_8_29_2
e_1_2_8_23_2
e_1_2_8_24_2
e_1_2_8_25_2
e_1_2_8_26_2
e_1_2_8_9_2
e_1_2_8_2_2
e_1_2_8_4_2
e_1_2_8_3_2
e_1_2_8_6_2
e_1_2_8_5_2
e_1_2_8_8_2
e_1_2_8_7_2
e_1_2_8_20_2
e_1_2_8_22_2
e_1_2_8_16_2
e_1_2_8_17_2
e_1_2_8_18_2
e_1_2_8_19_2
e_1_2_8_12_2
e_1_2_8_13_2
e_1_2_8_14_2
e_1_2_8_15_2
Weiss D.S. (e_1_2_8_21_2) 1997
e_1_2_8_31_2
e_1_2_8_30_2
e_1_2_8_10_2
e_1_2_8_11_2
e_1_2_8_32_2
21272746 - J Am Coll Cardiol. 2011 Feb 1;57(5):556-62
22897624 - Pacing Clin Electrophysiol. 2012 Oct;35(10):1179-87
23438053 - Pacing Clin Electrophysiol. 2013 May;36(5):578-90
18783391 - Value Health. 2009 Jun;12(4):568-73
15980420 - Am J Crit Care. 2005 Jul;14(4):294-303
14753636 - Europace. 2003 Oct;5(4):381-9
25983009 - J Am Coll Cardiol. 2015 Jun 23;65(24):2591-600
24067274 - Circ J. 2013;77(10):2419-31
14996583 - Am J Cardiol. 2004 Mar 1;93(5):582-7
17437568 - Pacing Clin Electrophysiol. 2007 Apr;30(4):463-71
23337265 - Circ J. 2013;77(5):1158-65
13688369 - Arch Gen Psychiatry. 1961 Jun;4:561-71
25218008 - Arch Cardiovasc Dis. 2014 Oct;107(10):508-18
15704778 - Mayo Clin Proc. 2005 Feb;80(2):232-7
16935995 - Circulation. 2006 Sep 5;114(10):e385-484
16784428 - Pacing Clin Electrophysiol. 2006 Jun;29(6):619-26
15914936 - Circ J. 2005 Jun;69(6):625-9
12202279 - Am J Psychiatry. 2002 Sep;159(9):1570-5
17473301 - JAMA. 2007 May 2;297(17):1909-16
18498951 - J Am Coll Cardiol. 2008 May 27;51(21):e1-62
25196176 - Pacing Clin Electrophysiol. 2014 Dec;37(12):1641-50
17369016 - J Anxiety Disord. 2008;22(2):187-98
11923652 - J Nerv Ment Dis. 2002 Mar;190(3):175-82
15927965 - Circulation. 2005 Jun 7;111(22):2898-905
19410106 - Gen Hosp Psychiatry. 2009 May-Jun;31(3):266-73
22240604 - Circ J. 2012;76(2):489-507
18042301 - Health Qual Life Outcomes. 2007 Nov 28;5:64
19170902 - Pacing Clin Electrophysiol. 2009 Feb;32(2):153-6
10877467 - J Clin Psychol. 2000 Jun;56(6):793-806
References_xml – volume: 57
  start-page: 556
  year: 2011
  end-page: 562
  article-title: Inappropriate implantable cardioverter‐defibrillator shocks: incidence, predictors, and impact on mortality
  publication-title: J Am Coll Cardiol
– volume: 14
  start-page: 294
  year: 2005
  end-page: 303
  article-title: Psychosocial issues of patients with implantable cardioverter defibrillators
  publication-title: Am J Crit Care
– volume: 29
  start-page: 619
  year: 2006
  end-page: 626
  article-title: Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors
  publication-title: Pacing Clin Electrophysiol
– volume: 76
  start-page: 489
  year: 2012
  end-page: 507
  article-title: Guidelines for risks and prevention of sudden cardiac death (JCS 2010)
  publication-title: Circ J.
– volume: 5
  start-page: 64
  year: 2007
  article-title: Recommended level of physical activity and health‐related quality of life among Japanese adults
  publication-title: Health Qual Life Outcomes
– volume: 37
  start-page: 1641
  year: 2014
  end-page: 1650
  article-title: Anxiety predicts mortality in ICD patients: results from the cross‐sectional national CopenHeartICD survey with register follow‐up
  publication-title: Pacing Clin Electrophysiol
– volume: 114
  start-page: e385
  year: 2006
  end-page: e484
  article-title: ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for practice guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
  publication-title: Circulation
– volume: 190
  start-page: 175
  year: 2002
  end-page: 182
  article-title: Reliability and validity of the Japanese‐language version of the impact of event scale‐revised (IES‐R‐J): four studies of different traumatic events
  publication-title: J Nerv Ment Dis
– volume: 77
  start-page: 1158
  year: 2013
  end-page: 1165
  article-title: Gender disparities in quality of life and psychological disturbance in patients with implantable cardioverter‐defibrillators
  publication-title: Circ J.
– volume: 51
  start-page: e1
  year: 2008
  end-page: 62
  article-title: ACC/AHA/HRS 2008 guidelines for device‐based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons
  publication-title: J Am Coll Cardiol
– volume: 77
  start-page: 2419
  year: 2013
  end-page: 2431
  article-title: Epidemiology of arrhythmias and sudden cardiac death in Asia
  publication-title: Circ J.
– volume: 28
  start-page: 263
  year: 2012
  end-page: 272
  article-title: Actual conditions of implantable defibrillation therapy over 5 years in Japan
  publication-title: J Arrhythmia
– volume: 159
  start-page: 1570
  year: 2002
  end-page: 1575
  article-title: A hazardous profession: war, journalists, and psychopathology
  publication-title: Am J Psychiatry
– volume: 107
  start-page: 508
  year: 2014
  end-page: 518
  article-title: Role of patient education in the perception and acceptance of home monitoring after recent implantation of cardioverter defibrillators: the EDUCAT study
  publication-title: Arch Cardiovasc Dis
– volume: 80
  start-page: 232
  year: 2005
  end-page: 237
  article-title: Implantable cardioverter‐defibrillators, induced anxiety, and quality of life
  publication-title: Mayo Clin Proc
– volume: 5
  start-page: 381
  year: 2003
  end-page: 389
  article-title: Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study
  publication-title: Europace
– volume: 69
  start-page: 625
  year: 2005
  end-page: 629
  article-title: Prevention of sudden cardiac death: lessons from recent controlled trials
  publication-title: Circ J.
– volume: 36
  start-page: 578
  year: 2013
  end-page: 590
  article-title: Behavioral interventions in patients with an implantable cardioverter defibrillator: lessons learned and where to go from here?
  publication-title: Pacing Clin Electrophysiol
– volume: 111
  start-page: 2898
  year: 2005
  end-page: 2905
  article-title: Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial
  publication-title: Circulation
– volume: 4
  start-page: 561
  year: 1961
  end-page: 571
  article-title: An inventory for measuring depression
  publication-title: Arch Gen Psychiatry
– volume: 297
  start-page: 1909
  year: 2007
  end-page: 1916
  article-title: A 59‐year‐old man considering implantation of a cardiac defibrillator
  publication-title: J Am Med Assoc
– volume: 31
  start-page: 266
  year: 2009
  end-page: 273
  article-title: A comparison of anxiety, depression and quality of life between device shock and nonshock groups in implantable cardioverter defibrillator recipients
  publication-title: Gen Hosp Psychiatry
– volume: 30
  start-page: 463
  year: 2007
  end-page: 471
  article-title: Quality of life among implantable cardioverter‐defibrillator recipients in the primary prevention therapeutic era
  publication-title: Pacing Clin Electrophysiol
– volume: 22
  start-page: 187
  year: 2008
  end-page: 198
  article-title: The impact of event scale‐revised: psychometric properties in a sample of motor vehicle accident survivors
  publication-title: J Anxiety Disord
– volume: 93
  start-page: 582
  year: 2004
  end-page: 587
  article-title: Psychosocial factors and quality of life in children and adolescents with implantable cardioverter‐defibrillators
  publication-title: Am J Cardiol
– volume: 35
  start-page: 1179
  year: 2012
  end-page: 1187
  article-title: Patients' attitudes and perceptions of implantable cardioverter‐defibrillators: potential barriers to appropriate primary prophylaxis
  publication-title: Pacing Clin Electrophysiol
– volume: 32
  start-page: 153
  year: 2009
  end-page: 156
  article-title: Does ICD indication affect quality of life and levels of distress?
  publication-title: Pacing Clin Electrophysiol
– volume: 56
  start-page: 793
  year: 2000
  end-page: 806
  article-title: Psychometric properties of the State‐Trait Anxiety Inventory among Japanese clinical outpatients
  publication-title: J Clin Psychol
– volume: 65
  start-page: 2591
  year: 2015
  end-page: 2600
  article-title: Remote monitoring of implantable cardioverter‐defibrillators: a systematic review and meta‐analysis of clinical outcomes
  publication-title: J Am Coll Cardiol
– volume: 12
  start-page: 568
  year: 2009
  end-page: 573
  article-title: Assessing items on the SF‐8 Japanese version for health‐related quality of life: a psychometric analysis based on the nominal categories model of item response theory
  publication-title: Value Health
– start-page: 399
  year: 1997
  end-page: 411
– ident: e_1_2_8_24_2
  doi: 10.1176/appi.ajp.159.9.1570
– ident: e_1_2_8_28_2
  doi: 10.1111/pace.12108
– ident: e_1_2_8_15_2
  doi: 10.1161/CIRCULATIONAHA.104.526673
– ident: e_1_2_8_23_2
  doi: 10.1097/00005053-200203000-00006
– ident: e_1_2_8_27_2
  doi: 10.1016/j.genhosppsych.2009.01.003
– ident: e_1_2_8_10_2
  doi: 10.1111/j.1540-8159.2007.00694.x
– ident: e_1_2_8_17_2
  doi: 10.1186/1477-7525-5-64
– ident: e_1_2_8_4_2
  doi: 10.4037/ajcc2005.14.4.294
– ident: e_1_2_8_7_2
  doi: 10.1253/circj.CJ-13-1129
– ident: e_1_2_8_12_2
  doi: 10.1111/pace.12490
– ident: e_1_2_8_19_2
  doi: 10.1016/S1099-5129(03)00078-3
– ident: e_1_2_8_13_2
  doi: 10.1253/circj.CJ-88-0022
– ident: e_1_2_8_16_2
  doi: 10.1111/j.1524-4733.2008.00449.x
– ident: e_1_2_8_18_2
  doi: 10.1002/(SICI)1097-4679(200006)56:6<793::AID-JCLP8>3.0.CO;2-4
– ident: e_1_2_8_32_2
  doi: 10.1016/j.jacc.2015.04.029
– ident: e_1_2_8_8_2
  doi: 10.1016/j.joa.2012.03.014
– ident: e_1_2_8_26_2
  doi: 10.1016/j.jacc.2010.06.059
– ident: e_1_2_8_3_2
  doi: 10.1016/j.jacc.2008.02.032
– ident: e_1_2_8_14_2
  doi: 10.1253/circj.69.625
– ident: e_1_2_8_9_2
  doi: 10.1111/j.1540-8159.2008.02196.x
– ident: e_1_2_8_31_2
  doi: 10.1016/j.acvd.2014.06.009
– ident: e_1_2_8_22_2
  doi: 10.1016/j.janxdis.2007.02.007
– ident: e_1_2_8_29_2
  doi: 10.1001/jama.297.17.1909
– ident: e_1_2_8_5_2
  doi: 10.4065/80.2.232
– start-page: 399
  volume-title: The impact of event scale‐revised
  year: 1997
  ident: e_1_2_8_21_2
– ident: e_1_2_8_25_2
  doi: 10.1016/j.amjcard.2003.11.022
– ident: e_1_2_8_6_2
  doi: 10.1111/j.1540-8159.2006.00409.x
– ident: e_1_2_8_20_2
  doi: 10.1001/archpsyc.1961.01710120031004
– ident: e_1_2_8_11_2
  doi: 10.1253/circj.CJ-12-1116
– ident: e_1_2_8_2_2
  doi: 10.1161/CIRCULATIONAHA.106.178233
– ident: e_1_2_8_30_2
  doi: 10.1111/j.1540-8159.2012.03497.x
– reference: 17473301 - JAMA. 2007 May 2;297(17):1909-16
– reference: 25218008 - Arch Cardiovasc Dis. 2014 Oct;107(10):508-18
– reference: 25983009 - J Am Coll Cardiol. 2015 Jun 23;65(24):2591-600
– reference: 16935995 - Circulation. 2006 Sep 5;114(10):e385-484
– reference: 11923652 - J Nerv Ment Dis. 2002 Mar;190(3):175-82
– reference: 15927965 - Circulation. 2005 Jun 7;111(22):2898-905
– reference: 15704778 - Mayo Clin Proc. 2005 Feb;80(2):232-7
– reference: 23438053 - Pacing Clin Electrophysiol. 2013 May;36(5):578-90
– reference: 14753636 - Europace. 2003 Oct;5(4):381-9
– reference: 13688369 - Arch Gen Psychiatry. 1961 Jun;4:561-71
– reference: 10877467 - J Clin Psychol. 2000 Jun;56(6):793-806
– reference: 17437568 - Pacing Clin Electrophysiol. 2007 Apr;30(4):463-71
– reference: 18498951 - J Am Coll Cardiol. 2008 May 27;51(21):e1-62
– reference: 19170902 - Pacing Clin Electrophysiol. 2009 Feb;32(2):153-6
– reference: 25196176 - Pacing Clin Electrophysiol. 2014 Dec;37(12):1641-50
– reference: 15914936 - Circ J. 2005 Jun;69(6):625-9
– reference: 16784428 - Pacing Clin Electrophysiol. 2006 Jun;29(6):619-26
– reference: 14996583 - Am J Cardiol. 2004 Mar 1;93(5):582-7
– reference: 19410106 - Gen Hosp Psychiatry. 2009 May-Jun;31(3):266-73
– reference: 23337265 - Circ J. 2013;77(5):1158-65
– reference: 24067274 - Circ J. 2013;77(10):2419-31
– reference: 22897624 - Pacing Clin Electrophysiol. 2012 Oct;35(10):1179-87
– reference: 18042301 - Health Qual Life Outcomes. 2007 Nov 28;5:64
– reference: 15980420 - Am J Crit Care. 2005 Jul;14(4):294-303
– reference: 12202279 - Am J Psychiatry. 2002 Sep;159(9):1570-5
– reference: 22240604 - Circ J. 2012;76(2):489-507
– reference: 17369016 - J Anxiety Disord. 2008;22(2):187-98
– reference: 18783391 - Value Health. 2009 Jun;12(4):568-73
– reference: 21272746 - J Am Coll Cardiol. 2011 Feb 1;57(5):556-62
SSID ssj0058411
Score 2.0807307
Snippet Abstract Background Implantable cardioverter-defibrillators (ICDs) have been established for primary and secondary prevention of fatal arrhythmias. However,...
Background Implantable cardioverter‐defibrillators (ICDs) have been established for primary and secondary prevention of fatal arrhythmias. However, little is...
Implantable cardioverter-defibrillators (ICDs) have been established for primary and secondary prevention of fatal arrhythmias. However, little is known about...
Background: Implantable cardioverter-defibrillators (ICDs) have been established for primary and secondary prevention of fatal arrhythmias. However, little is...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
wiley
elsevier
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 102
SubjectTerms Analysis
Anxiety
Cardiovascular
Defibrillators
Health aspects
Implantable cardioverter-defibrillator
Implants, Artificial
Original
Prevention
Primary prevention
Prosthesis
Quality of life
Secondary prevention
Stress (Psychology)
Surveys
SummonAdditionalLinks – databaseName: Wiley Online Library Open Access
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ba9RAFB5KBfFF6j22ygiCIKTOLZnkcS2WWqgKWujbMLfYLjVZui366E_wN_pLPGeSLJt9UHzMzGQ3c-ZcZ875hpCX2kVZxcDzuvEhV5FVuWUWHLnGxlBK7lnEQPHkQ3l0qo7PirMtcjDWwvT4EKsNN5SMpK9RwK1brsWb8_15h8BBvNhP6Vmgh29hiS3e3yDUp1Edg4FNl_Ai7liuhC7Ho82U5LXxExPjlDD8JzZqU2mvWa3NjMp1TzeZqsMdcnfwMemsZ4p7ZCu298ntk-EU_QH5_n68mYR2DV30eBPUtoEuMTwO-LQYoJ26luKp9rCxR-HRtj8wz5OmlGYK_iO9-La4hAXCIizq-_zWiJmiv3_-CrHBmgLgNYjtH5LTw3dfDo7y4QKG3IOYirzWsrYQPfO6CFKwplReVLaoXFXVCEMfysBsGSwEQVZ6CCS546X3hQuucdJ6-Yhst10bnxAqBLOK-1qDTVZKhSpwp4Jz0jnwUSXLCBspb_yATo6XZFyaMQ1tbmCxDC4WNsFiZeT16pWBVH8b_BaXczUQUbVTQ3f11QxCapwSXnvHeGBR8QgfqerG2SIKK7UXTUb0yAxmLFwFVRuXg9wvDTdLYZj5jNyGzAbudgIwysgr5B2DWgOm5e1Q_ADEQfwtM9O4CQWupMzI3mQkSLufdL8Yuc9gF6bItbG7gb8GX68ChVrBmMc9N65mKzSrwTQBlfWETyfkmPa0F-cJbFxVCIgEE3iTOPrflDbHH2cQM4in__3GLrkDrWWfF7VHtq-vbuIzcPmu3fMk0n8ANlVR3g
  priority: 102
  providerName: Wiley-Blackwell
Title Influence of primary and secondary prevention indications on anxiety about the implantable cardioverter-defibrillator
URI https://www.clinicalkey.es/playcontent/1-s2.0-S1880427615001404
https://onlinelibrary.wiley.com/doi/abs/10.1016%2Fj.joa.2015.10.002
https://www.ncbi.nlm.nih.gov/pubmed/27092190
https://www.proquest.com/docview/1782831983
https://pubmed.ncbi.nlm.nih.gov/PMC4823574
https://doaj.org/article/b42c7cb01d0e41ed8d49fba5e2a37c2f
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1baxQxFA5aQXwR767WJYIgCGNzm8nM41a31EIvqJV9C7kNttSZxe2CP99zMjPLTh_siy8LmWR3yTlfzmVy8oWQd9pFWcbAs6r2IVORlZllFgK52sZQSO5ZxETx-KQ4PFdHi3yxddUX1oR19MCd4PacEl57x3hgUfEYyqCq2tk8Ciu1FzVaX1axIZnqbDB41XTzLpKNZUroYtjPTJVdly0SDvH8YyrrEiOPlIj7R47ppqXeclU3yyi3w9vknw4ekYd9YEln3YQekzuxeULuH_db50_J-stwHQlta7rsSCaobQJdYU4csLXs-ZzahuJWdv82j0LTNn-wuJOmOmYKQSO9-LW8Aq3gySvqu6LWiOWhWYg1HiMAeEE6_4ycH8y_fzrM-jsXMg8rU2SVlpWFhJlXeZCC1YXyorR56cqyQub5UARmi2Ah77HSQ-7IHS-8z11wtZPWy-dkp2mb-JJQIZhV3Fca3LBSCjTHnQrOSecgLJVsQtggd-N7QnK8F-PKDJVnlwZUZVBV-AhUNSEfNl_pBfWvwfuozM1AJNJODwBepoeXuQ1eE6IHKJjhrCpY17jql_rKcLMShplviDWEGkTYibNoQt4jcgwaCpiWt_15BxAOUm6Zmcb3ThA9ygnZHY2EBe5H3W8H7Bnswqq4JrZr-GsI70qwoSWMedFhcTNboVkF3gikrEcoHYlj3NNc_Ez84qpEDiSYwF7C8-2SNkenM0gTxKv_IfHX5AH8dNFVR-2Snevf6_gGAr9rNyV3hTqDT73QU3Jvf35y9nWa1j20Tn_M55__AnUSWz0
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Jb9QwFLaqIgEXxN5pCxgJCQkpxVu247BU09IpSLRSb5a3QEclGXVawZGfwG_kl_Cek4wmcwBxTOLMxM9vtT9_JuRFboMsgudJWTmfqMCKxDADiVxlgs8kdyxgoTg9zian6vAsPdsg7_q9MC0_xHLCDS0j-ms0cJyQXik4Z3uzBpmDeLoX8VngiG8oyM8R2CfUp94fQ4SNp_Ai8ViiRJ71a5sR5bX2E4PoFEn8B0Fq3WuvhK11SOVqqhtj1f5dcqdLMum41Yp7ZCPU98nNabeM_oB8P-iPJqFNRect4QQ1tacLrI89Xs07bqempris3c3sUbg09Q8EetKIaaaQQNLzb_MLGCHchUVdC3ANCBX9_fOXDxVuKgBlg-L-ITndf3_ydpJ0JzAkDuxUJGUuSwPlMy9TLwWrMuVEYdLCFkWJPPQ-88xk3kAVZKSDSpJbnjmXWm8rK42Tj8hm3dRhi1AhmFHclTkEZaWULzy3ylsrrYUkVbIRYb3ktevoyfGUjAvd49BmGgZL42DhLRisEXm1fKUT1d8av8HhXDZEWu14o7n8ojsr1VYJlzvLuGdB8QAfqcrKmjQII3MnqhHJe2XQ_c5V8LVh0Rn-QnO9EJrpz6htqGyQb0cGoxF5ibqj0W1At5zpdj-AcJCAS49znIWCXFKOyO6gJZi7Gzx-3mufxkeIkatDcw1_DcleAR61gDaPW21c9lbkrITYBFLOB3o6EMfwSX3-NbKNqwIZkaADr6NG_1vS-vDjGIoGsf3fbzwjtyYn0yN9dHD8YYfchhZZC5LaJZtXl9fhCeR_V_ZpNO8_dFBVUQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLamTZp4QdwpDDASEhJShu04t8cyqLbBBhIUTbxYvmWsGkm1boJHfgK_kV_COY5TNX0A8ZjEaePj79zs48-EPCuMT0vveFLV1iXSszLRTEMgV2vv8pRb5jFRPDrO96fy8CQ72SB7_V6Yjh9iOeGGmhHsNSr43NUr-eZsd9YicRDPdkN5FtjhLWTLA7BvjT9Pv0x7gwwuNhzDi8xjiRRF3i9uhjKvtR8ZuKfA4j_wUutme8VvrddUrsa6wVlNbpDrMcqk4w4WN8mGb26R7aO4jn6bfD_ozyahbU3nHeME1Y2jC0yQHV7NI7lT21Bc145TexQudfMDKz1pKGqmEEHSs2_zcxgi3IZFbVfh6rFW9PfPX87XuKsA0AbZ_R0ynbz5tLefxCMYEguKKpKqSCsN-TOvMpcKVufSilJnpSnLConoXe6Yzp2GNEinFlJJbnhubWacqU2qbXqXbDZt4-8TKgTTktuqAK8spXSl40Y6Y1JjIEpN2YiwXvLKRn5yPCbjXPWFaDMFg6VwsPAWDNaIvFi-EkX1t8avcDiXDZFXO9xoL05VVFNlpLCFNYw75iX38JGyqo3OvNBpYUU9IkUPBtVvXQVj6xdR8xeKq4VQTH1EtCHYIOAOFEYj8hyxo9BuQLesjtsfQDjIwKXGBU5DQTCZjsjOoCXoux08ftqjT-EjLJJrfHsFfw3RXgkmtYQ29zo0LnsrClaBcwIpFwOcDsQxfNKcfQ1047JESiTowMuA6H9LWh2-H0PWIB789xtPyPaH1xP17uD47UNyDRrkXZHUDtm8vLjyjyD-uzSPo37_AWIhVkA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influence+of+primary+and+secondary+prevention+indications+on+anxiety+about+the+implantable+cardioverter-defibrillator&rft.jtitle=Journal+of+arrhythmia&rft.au=Anita+Rahmawati%2C+MD&rft.au=Akiko+Chishaki%2C+MD%2C+PhD&rft.au=Tomoko+Ohkusa%2C+MD%2C+PhD&rft.au=Hiroyuki+Sawatari%2C+RN%2C+PhD&rft.date=2016-04-01&rft.pub=Wiley&rft.issn=1880-4276&rft.volume=32&rft.issue=2&rft.spage=102&rft.epage=107&rft_id=info:doi/10.1016%2Fj.joa.2015.10.002&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_b42c7cb01d0e41ed8d49fba5e2a37c2f
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F18804276%2FS1880427616X00038%2Fcov150h.gif